Prostate Cancer Indicators Prostate Acid Phosphatase（PACP）Test Kit Tumor Maker Assay For Clinical In Vitro Diagnostic

Prostate Cancer Indicators Prostate Acid Phosphatase(PACP) test kit Tumor Maker Assay for Clinical In Vitro Diagnostic

^{_{Clinical Significance}}

^{Prostatic acid phosphatase (PAP) is a glycoprotein (molecular weight 100,000) synthesized and secreted by mature prostate epithelial cells. It enters the seminal vesicle through the prostate duct and is excreted from the urethra. In prostate cancer, the prostatic acid phosphatase produced by cancer cells is directly absorbed into the blood circulation because there are no ducts or the gland ducts are destroyed by the cancer cells, resulting in an increase in serum prostatic acid phosphatase.}

^{Abnormal results: This method can be used for the diagnosis, treatment effect and prognosis evaluation of prostate cancer and differential diagnosis of metastatic bone tumors. It has been reported that 80% of prostate cancer patients with bone metastases have elevated prostatic acid phosphatase. Serum prostatic acid phosphatase can be elevated in some patients with benign prostatic hyperplasia, and clinical judgment and follow-up observation should be made at this time. The recent digital rectal examination of the prostate can cause an increase in serum prostatic acid phosphatase, so it is appropriate to collect blood before the examination or 2 weeks after the examination. Specimens should not be hemolyzed, otherwise the measurement results may be abnormal. People who need to be checked: People with symptoms such as frequent urination, urgency, urinary retention, dysuria, difficulty in forming urine flow, hematuria, and bone pain.}

^{Related diseases
Prostate cancer, gastrointestinal cancer, prostatitis in the elderly}

CLIA Reagents of Tumor Maker(PACP)

Zecen Biotech CO., LTD., founded in 2011, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Zecen focus on the Chemiluminescent immunoassay (CLIA) field. With all products CE marked, our market presence currently spreads from across China to other countries including India, Switzerland, Russia etc., Zecen is expanding its footprint to become a global brand.

Zecen is the only enterprise with independent intellectual property rights in the entire chemiluminescence industry chain in China, including reagent, instrument, magnetic microbead, and reagent raw material. Our current products include more than 100 assays, from thyroid, inflammation, diabetes, tumer markers, immune disorders, hormones to cardiac markers. Our ever-expanding test menu helps our customers and collaborators keep up with the demands of healthcare sector. Zecen is striving for innovation and perfection to deliver the best products to the customers.

As a manufacturer, Zecen provide the OEM, ODM and other customized service of all products. We have the core R&D centers and innovative ability to lay a solid foundation for developing the broadest range of CLIA analyzers and test menu. High-quality sales and after-sales links provide the more intimate service. The patent and CE certification give us the confident sending all over the world, and more than 50 companys in the requiement of customized and have a long term coorperation with Zecen.